SEC Form 4 · accession 0001179110-19-000933
RIGEL PHARMACEUTICALS INC · RIGL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Anne-Marie Duliege
Officer — EVP & Chief Medical Officer
Period of report
Jan 23, 2019
Accepted (ET)
Jan 25, 2019 · 6:23 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001034842
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $2.00 | Jan 23, 2019 | A | 162,500 | A | — | Jan 23, 2029 | Common Stock | 162,500 | 162,500 | D |
Explanation of responses
- F1The shares of common stock subject to the option vest in equal monthly installments over four (4) years from the vesting commencement date of January 1, 2019.